Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation
AssigneeEli Lilly and Company
InventorAlan D. Palkowitz
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorAlan D. Palkowitz
Estimating the term…
The present invention provides pharmaceutically active compounds of formula I ##STR1## wherein R.sup.1 is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --OCOC.sub.6 H.sub.5, --OCO(C.sub.1 -C.sub.6 alkyl), or --OSO.sub.2 (C.sub.2 -C.sub.6 alkyl); R.sup.2 is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --OCOC.sub.6 H.sub.5, --OCO(C.sub.1 -C.sub.6 alkyl), --OSO.sub.2 (C.sub.2 -C.sub.6 alkyl), or halo, providing when Z is --S--, R.sup.2 is not halo; R.sup.3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; n is 2 or 3; and z is --O-- or --S--; or a pharmaceutically acceptable salt thereof, for inhibiting aortal smooth muscle proliferation.
A method for inhibiting aortal smooth muscle cell proliferation comprising administering to a human in need of treatment an effective amount of a compound of formula I ##STR66## wherein R.sup.1 is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --OCOC.sub.6 H.sub.5, --OCO(C.sub.1 -C.sub.6 alkyl), or --OSO.sub.2 (C.sub.2 -C.sub.6 alkyl);
Dependencies are inferred from the claim text.